Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priority

New Delhi: Patient safety and product quality are its highest priorities Pfizer India has said, reacting to the Karnataka Food and Drug Administration (FDA) action regarding the circulation of counterfeit drugs.

The Karnataka health regulator on Sunday said it has cancelled 16 drug licences of retailers and wholesalers and suspended eight others in connection with the alleged distribution and sale of spurious medicines.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.